Professional Bio
Dr. Mark B. Taubman received his BA in Biochemistry from Columbia University and his M.D. from New York University School of Medicine. He subsequently completed a Residency in Internal Medicine and a Fellowship in Cardiovascular Diseases at the Brigham and Women's Hospital of Harvard Medical School. After 5 years on the faculty of the Brigham and Women's Hospital, he joined the Mount Sinai School of Medicine in New York, where he developed a well-funded research program in vascular biology, focusing on the regulation of pro-inflammatory and pro-thrombotic molecules in smooth muscle cells and in the arterial wall.
In addition to his research program, Dr. Taubman was the Director of the Cardiology Fellowship, the Principal Investigator of an NIH training grant in Molecular Cardiology, and the Director of the Medical Scientist Training Program (MD-PhD). In 2003, Dr. Taubman moved to the University of Rochester as Chief of the Cardiology Division, and the Director of the Cardiovascular Research Institute. In 2007, Dr. Taubman was appointed Chairman of the Department of Medicine. Dr. Taubman has served as a charter member of the AICS study section of the NHLBI and the Chairman of the Research Committee of the National American Heart Association (AHA). In 2006, in recognition of his contributions to vascular biology, he received the Russell Ross Memorial Award of the Arteriosclerosis, Thrombosis, and Vascular Biology Council of the AHA. In 2007, Dr. Taubman was named Editor-in-Chief of the AHA journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Research Bio
Dr. Mark B. Taubman received his BA in Biochemistry from Columbia University and his M.D. from New York University School of Medicine. He subsequently completed a Residency in Internal Medicine and a Fellowship in Cardiovascular Diseases at the Brigham and Women's Hospital of Harvard Medical School. After 5 years on the faculty of the Brigham and Women's Hospital, he joined the Mount Sinai School of Medicine in New York, where he developed a well-funded research program in vascular biology, focusing on the regulation of pro-inflammatory and pro-thrombotic molecules in smooth muscle cells and in the arterial wall.
In addition to his research program, Dr. Taubman was the Director of the Cardiology Fellowship, the Principal Investigator of an NIH training grant in Molecular Cardiology, and the Director of the Medical Scientist Training Program (MD-PhD). In 2003, Dr. Taubman moved to the University of Rochester as Chief of the Cardiology Division, and the Director of the Cardiovascular Research Institute. In 2007, Dr. Taubman was appointed Chairman of the Department of Medicine. Dr. Taubman has served as a charter member of the AICS study section of the NHLBI and the Chairman of the Research Committee of the National American Heart Association (AHA). In 2006, in recognition of his contributions to vascular biology, he received the Russell Ross Memorial Award of the Arteriosclerosis, Thrombosis, and Vascular Biology Council of the AHA. In 2007, Dr. Taubman was named Editor-in-Chief of the AHA journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
| Alpha Omega Alpha |
2004 |
| Special Recognition Award, Council on Arteriosclerosis,
Thrombosis, and Vascular Biology |
2002 |
| Distinguished Research Award, Department of Medicine,
Mount Sinai School Of Medicine |
1996 |
| Irma T. Hirschl Award
"Isolation and characterization of genes regulating blood vessel growth |
1991 - 1995 |
| NIH Clinical Investigator Award
"Vascular smooth muscle cDNA contractile protein clones"
Boston Children's Hospital, Boston, MA |
1984 - 1989 |
| NIH Institutional Training Grant for Cardiovascular Research
Brigham & Women's Hospital, Boston, MA |
1983 - 1984 |
| NIH Training Grant
Medical Scientist Training Program,
New York University School of Medicine, New York, NY |
1972 - 1978 |
2010 Mar
Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP. "Platelets and megakaryocytes contain functional nuclear factor-kappaB." Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar 0; 30(3):591-8. Epub 2009 Dec 30. |
2009 Nov
Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP. "Foxp3 regulates megakaryopoiesis and platelet function." Arteriosclerosis, thrombosis, and vascular biology. 2009 Nov 0; 29(11):1874-82. Epub 2009 Aug 06. |
2009 May
Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA. "Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study." Cancer investigation. 2009 May 0; 27(4):430-4. |
2009 Jan 15
Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB. "Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury." Blood. 2009 Jan 15; 113(3):705-13. Epub 2008 Oct 17. |
2009
Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. "The platelet as an immune cell-CD40 ligand and transfusion immunomodulation." Immunologic research. 2009 45(2-3):251-60. Epub 2009 Jan 29. |
